TELA Bio (TELA) Cash from Financing Activities (2018 - 2026)
TELA Bio has reported Cash from Financing Activities over the past 8 years, most recently at $25.8 million for Q4 2025.
- For Q4 2025, Cash from Financing Activities fell 39.77% year-over-year to $25.8 million; the TTM value through Dec 2025 reached $25.8 million, down 40.2%, while the annual FY2025 figure was $25.8 million, 40.2% down from the prior year.
- Cash from Financing Activities for Q4 2025 was $25.8 million at TELA Bio, up from $24000.0 in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $46.4 million in Q2 2023 and troughed at -$235000.0 in Q1 2023.
- A 5-year average of $7.8 million and a median of $63500.0 in 2023 define the central range for Cash from Financing Activities.
- Biggest five-year swings in Cash from Financing Activities: crashed 505.56% in 2022 and later surged 194936.36% in 2024.
- Year by year, Cash from Financing Activities stood at $174000.0 in 2021, then plummeted by 225.86% to -$219000.0 in 2022, then skyrocketed by 110.05% to $22000.0 in 2023, then surged by 194936.36% to $42.9 million in 2024, then tumbled by 39.77% to $25.8 million in 2025.
- Business Quant data shows Cash from Financing Activities for TELA at $25.8 million in Q4 2025, $24000.0 in Q3 2025, and -$3000.0 in Q2 2025.